Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer

NCT03344172 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Suspected Serious Adverse Events related to treatment

Conditions

Pancreatic Cancer Resectable

Interventions

DRUG: Gemcitabine, Nab-Paclitaxel, hydroxychloroquine and Avelumab
DRUG: Gemcitabine, Nab-Paclitaxel, and hydroxychloroquine

Sponsor

Nathan Bahary, MD

Collaborators

[object Object]
[object Object]